HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges

By , Maxwell Nwegbu, Obiageli Nnodu, Hezekiah Isa, Chinatu Ohiaeri, and Samuel Adegoke Et Al